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Tissue-resident memory T (Trm) cells contribute to
local immune protection in non-lymphoid tissues
such as skin and mucosa, but little is known about
their transcriptional regulation. Here we showed
that CD8+CD103+ Trm cells, independent of circu-
lating memory T cells, were sufficient for protection
against infection and described molecular elements
that were crucial for their development in skin and
lung. We demonstrated that the T-box transcription
factors (TFs) Eomes and T-bet combined to control
CD8+CD103+ Trm cell formation, such that their coor-
dinate downregulation was crucial for TGF-b cyto-
kine signaling. TGF-b signaling, in turn, resulted in
reciprocal T-box TF downregulation. However,
whereas extinguishment of Eomes was necessary
for CD8+CD103+ Trm cell development, residual
T-bet expression maintained cell surface inter-
leukin-15 (IL-15) receptor b-chain (CD122) expres-
sion and thus IL-15 responsiveness. These findings
indicate that the T-box TFs control the two cytokines,
TGF-b and IL-15, which are pivotal for CD8+CD103+
Trm cell development and survival.
INTRODUCTION
Memory CD8+ T cells in the blood have traditionally been classi-
fied as belonging to one of two subsets: central memory T (Tcm)
cells that express the lymphoid homing markers CCR7 and
CD62L, and effector memory T (Tem) cells that largely lack these
receptors but instead express markers that allow them to enter
peripheral tissues (Sallusto et al., 1999). When memory T cells
were detected in the periphery, it was previously thought that
these were Tem cells in transit through the body (Masopust
et al., 2001; Reinhardt et al., 2001). However, more recentImmstudies have determined that a proportion of T cells found in
the tissues do not recirculate and instead represent a distinct
population of tissue-resident memory T (Trm) cells. Initially
described in detail in the skin (Gebhardt et al., 2009) and gut
(Masopust et al., 2010), these cells have now been found in a
variety of tissues and organs in both humans and mice (Casey
et al., 2012; Sathaliyawala et al., 2013).
Trm cells often carry markers that are largely absent from
memory cells in the circulation. Two such molecules are sur-
face-expressed CD69 and CD103 (Mackay et al., 2013). CD69
is usually seen as an activation marker, but it can be upregulated
in an antigen-independent fashion on T cells found in peripheral
tissues (Casey et al., 2012; Mackay et al., 2013; Shin and Iwa-
saki, 2012). CD103, which is the integrin aEb7, is driven by local
transforming growth factor b (TGF-b) and its appearance is de-
layed in comparison to CD69 (Mackay et al., 2013). Although
CD103 detection was originally used in the early analyses of
Trm cell development and function (Gebhardt et al., 2009; Maso-
pust et al., 2010), more recent discussions have focused on a
broader Trm cell definition (Steinert et al., 2015; Thome et al.,
2014; Watanabe et al., 2015). CD69 is found on the majority of
Trm cells regardless of CD103 expression, and bona fide CD69+
CD103 Trm cells have clearly been shown to exist (Steinert
et al., 2015; Watanabe et al., 2015). However, given that CD69
is upregulated quite early in Trm cell development, at a time
when tissue-egress mechanisms are not completely extin-
guished (Mackay et al., 2013; Skon et al., 2013), it remains
possible that a fraction of T cells expressing this molecule can
still return to the circulation. Thus, CD69 might not be a reliable
marker of obligatory residency. This is particularly pertinent in
the case of peripheral tissues such as skin, which contain a num-
ber of distinct resident and recirculating populations (Watanabe
et al., 2015). In addition, Trm cell activation can promote recruit-
ment of cells from the circulation (Schenkel et al., 2013), compli-
cating the relative contribution of resident and recirculating
T cells to overall peripheral immune control.
In contrast to this uncertainty regarding CD69+ Trm cells, the
CD103+ subset of CD8+ Trm cells are likely to represent a truly
resident population in a variety of critical locations. These cellsunity 43, 1101–1111, December 15, 2015 ª2015 Elsevier Inc. 1101
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Figure 1. CD8+CD103+ Trm Cells Protect against Infection with HSV
in the Absence of Circulating Memory
Mice were seeded with in vitro activated gBT-I.Thy1.1+ T cells and treated with
DNFB on one skin flank to lodge Trm cells. At > 30 days post DNFB treatment,
mice (as indicated) were treated with anti-Thy1.1 antibody to deplete circu-
lating Thy1.1+ cells.
(A) Enumeration of gBT-I T cells in spleen and skin (CD103+ Trm cells) and (B)
co-expression of CD103 and CD69 by gBT-I T cells in skin, in antibody treated
(+ aThy1.1) and non-treated (Ctrl) cohorts, at 7 days post antibody treatment.
(C) Cohorts of mice that received gBT-I.Thy1.1+ T cells and were treated with
depleting antibody (gBT-I + Thy1.1) or that did not receive gBT-I T cells (no
gBT-I) were infected with HSV on both DNFB-treated (‘‘DNFB,’’ green circles)
and non-treated (‘‘Ctrl,’’ open circles) skin flanks > 30 days post DNFB-
treatment and 7 days post antibody treatment. Shown are viral titers in the skin
6 days after HSV infection in the described cohorts. Symbols represent indi-
vidual mice; bars represent the mean. Data are pooled from two experiments.
Error bars represent mean ± SEM.dominate the epithelia of the small intestine and skin, where they
remain in disequilibrium from the blood over the long term (Jiang
et al., 2012; Klonowski et al., 2004). Such surfaces are common
pathogen entry points in the body, indicating that the intra-
epithelial CD8+CD103+ Trm cells might provide the first line-
defense against many infectious agents. The CD8+CD103+
Trm cells are transcriptionally distinct from their CD103 negative
tissue counterparts (Bergsbaken and Bevan, 2015; Wakim et al.,
2012), as well as from Tem and Tcm cells in the circulation
(Mackay et al., 2013). It has been shown that CD103 induction re-
quires either local antigen recognition by Trm cells or their spe-
cific localization within the tissue (Mackay et al., 2012; Wakim
et al., 2010), arguing that CD103+ Trm cells likely represent
late-stage tissue residents (Mackay et al., 2013).
One common feature of themature CD8+CD103+ Trm cells in a
range of different tissues is the near-extinguishment of Eomeso-
dermin (Eomes) (Mackay et al., 2013; Wakim et al., 2012). Eomes
is a T-box transcription factor (TF), which, along with the related
homolog T-bet, is a major player in shaping the development of a
range of cells belonging to the innate and adaptive arms of the
immune system (Kaech and Cui, 2012). Eomes expression is up-
regulated in long-lived memory cells, whereas T-bet expression
is highest in short-lived effector cells (Joshi et al., 2007). In terms
of tissue T cells, it is known that T-bet downregulation is required
for optimal CD8+CD103+ Trm cell development or survival in the
lung (Laidlaw et al., 2014). However, T-bet and Eomes share
cooperative functions (Banerjee et al., 2010; Intlekofer et al.,
2005; Pearce et al., 2003), indicating that Eomes modulation
might also play an equally important role in Trm cell formation.
Here we examined how the combination of T-bet and Eomes
controlled Trm cell development, focusing on CD8+CD103+
Trm cells, which we showed had stand-alone protective capabil-
ities in the absence of any contribution from the circulation.
We further showed that the coordinated downregulation of
both T-box TFs was required for optimal TGF-b signaling, lead-
ing to efficient CD8+CD103+ Trm cell development. However,
while Eomes was effectively extinguished during Trm cell
development, there was residual T-bet expression. The latter
promoted interleukin-15 receptor (IL-15R) b-chain (CD122)
expression and was required for long-term Trm cell survival.
Therefore, while Trm cell development required the downregula-
tion of both T-box TFs, the contribution of T-bet was distinct in
that ongoing low-level expression of this TF was necessary to
maintain IL-15 signaling and CD8+CD103+ Trm cell development
and survival.
RESULTS
CD8+CD103+ Trm Cells Protect Skin against Herpes
Simplex Virus Infection in the Absence of Circulating
Memory T Cell Contribution
Trm cells can recruit memory T cells from the blood (Schenkel
et al., 2013), which leaves open the possibility that Trm cell-
mediated protection is completely dependent on the presence
of circulating T cells. We wanted to see whether CD8+ Trm cells
alone could control infection in the absence of input from the
circulating memory pool. To do this, we took advantage of
the observation that systemic treatment with depleting anti-
bodies eliminates circulating T cells, including memory cells,1102 Immunity 43, 1101–1111, December 15, 2015 ª2015 Elsevier Inwhile leaving peripheral populations largely intact (Schenkel
et al., 2013). To this end, we adoptively transferred in vitro-
activated congenically marked Thy1.1+ transgenic (gBT-I)
T cells specific for the immunodominant determinant from
herpes simplex virus (HSV) and then recruited them into the
skin of C57BL/6 recipient mice via the induction of a local non-
specific inflammatory reaction using the contact sensitizer
DNFB, as previously described (Mackay et al., 2012). Intrave-
nous administration of anti-Thy1.1 antibody was then used to
eliminate all circulating HSV-specific T cells, including gBT-I
T cells in the spleen, while sparing the Trm cell counterparts in
the skin (Figure 1A). At the time of treatment (4 weeks after
DNFB induced Trm cell lodgement), around 30% of skin gBT-I
T cells were negative for CD103 and a high proportion of
these expressed CD69 (Figure 1B). The anti-Thy1.1 antibody
selectively eliminated all cells lacking CD103, which included a
fraction of cells that expressed only CD69. There was virtually
no loss of CD103+ gBT-I T cells, defining them as separate
from the circulation and thus true resident cells. To examine
the functional capabilities of CD8+CD103+ Trm cells, we then
challenged antibody-ablated and control mice with HSV on
the left (DNFB treated) flank that contained the Trm cells (in the
gBT-I group) and right flank lacking this population (Ctrl). The
presence of infectious virus was assessed 6 days later. The re-
sults in Figure 1C show that CD103+ Trm cells effectivelyc.
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Figure 2. Expression of T-box Transcription
Factors during Trm Cell Maturation in Skin
Mice received naive congenically marked gBT-I
T cells and were infected on the flank with HSV.
gBT-I T cells were tracked throughout the response
based on their expression of Va2, CD45.2, and
CD45.1.
(A) Intracellular staining for Eomes and T-bet
expression by gBT-I T cells in skin (orange line) and
spleen (black line) > 4 weeks p.i. Isotype control
staining is also shown (gray filled line).
(B) gBT-I T cells from skin 8 days and 14 days p.i.
were sorted as indicated (Sk, total skin; Der, dermis;
Epi, epidermis). Shown is qPCR analysis of Eomes
expression during Trm cell differentiation. Median
values were calculated relative to Hprt and
normalized to Trm cell values. Data are pooled from
three experiments (n = 15).
(C) Expression of Eomes and CD103 or (D) T-bet
and CD103 by gBT-I T cells in skin and epidermis
(Epi) at the indicated times p.i.; numbers depict
percent events in respective gates. Data are repre-
sentative of three experiments.controlled local HSV replication in the absence of the circulating
populations. Combined, these results define the CD103+ subset
of CD8+ Trm cells as a true tissue-resident population that can
directly protect skin against HSV challenge in the absence of
circulating antigen-specific memory T cells.
T-box Transcription Factors Are Downregulated during
CD8+CD103+ Trm Cell Maturation with Complete
Shut-Down of Eomes Expression
We had previously carried out a detailed comparison of genes
differently regulated in memory T cells resident in a variety of
tissues to identify a core transcriptional signature of the
CD103+ Trm cell population (Mackay et al., 2013). As part of
this signature, we found that Eomes transcription was strikingly
downregulated in CD8+CD103+ Trm cells compared to circu-
lating Tem or Tcm populations. Because both T-box TFs Eomes
and T-bet can influence memory T cell development (Kaech and
Cui, 2012), we were interested in tracking their coordinated
expression during Trm cell maturation. Figure 2A shows that
skin memory gBT-I T cells had no detectable intracellular Eomes
expression after the resolution of HSV replication, whereas their
splenic counterparts were Eomes positive. At this time, T-bet
expression was similarly downregulated in skin memory
T cells, although less so than Eomes (Figure 2A).
One of the advantages of the HSV skin infection model is that
the development of skin Trm cells and the acquisition of the
mature CD103+ phenotype occurs in a progressive fashion,
from the time T cells enter the skin during the effector response,
to their entry into the epidermal layer and finally their surface
acquisition of CD103 (Mackay et al., 2013). This allows the fine
delineation of the molecular changes that occur during Trm
cell maturation, as it is easy to separate epidermis (consisting
exclusively of epithelium) from the dermis (which is largely non-
epithelium, except for the hair follicles). Quantitative PCRImm(qPCR) analysis showed that virus-specific T cells had high
Eomes transcript levels just after infection was cleared from
the skin at day 8 after inoculation (Figure 2B). Transcription of
this gene was progressively extinguished as the T cells subse-
quently migrated from the dermis to the epidermis and then in
the latter compartment, converted to the mature CD103+ form.
This Eomes shut-down in skin T cells was also evident at the pro-
tein level, as determined by flow cytometry (Figure 2C). At later
times after the resolution of HSV skin infection, most gBT-I
T cells localized to the epithelium, such that by 4 weeks after
infection, the pattern of staining for whole skin and epidermis
had coalesced (Figure 2C). T-bet protein levels also declined af-
ter HSV infection (Figure 2D), although not to the same extent as
seen with Eomes. Overall, these results show that expression of
both T-box TFs is downregulated during CD8+ Trm cell develop-
ment in the skin, with the lowest amounts found in the most
mature CD103+ subset in the epidermis.
Forced Expression of T-box Transcription Factors
Inhibits Trm Cell Formation in the Skin Epidermis
The data suggested that T-box TF downregulation might be
required for Trm cell formation. To formally prove this, we forced
the expression of either Eomes or T-bet in maturing Trm cells.
We had previously shown that activated CD8+ T cells injected
into mouse skin are able to migrate into the epidermis and
form stable Trm cells (Mackay et al., 2013). This approach al-
lowed us to test whether T cells transduced to express Eomes
or T-bet using recombinant retrovirus would be compromised
in their ability to migrate to the epidermis and acquire the mature
CD103+ Trm cell phenotype.
Infection with recombinant retroviruses resulted in approxi-
mately 60%–90% transformation of T cells as determined by
GFP expression. The transduced cells had high levels of T-box
TF expression compared to cells transduced with the controlunity 43, 1101–1111, December 15, 2015 ª2015 Elsevier Inc. 1103
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Figure 3. Forced Expression of T-box Transcription Factors Inhibits Trm Cell Formation in the Skin Epidermis
In vitro activated CD8+ T cells were transduced with either control-GFP (Ctrl) retrovirus or (A) Eomes-GFP (Eomes+), or (B) T-bet-GFP (T-bet+) retrovirus. Equal
numbers of GFP-expressing cells were injected intradermally into separate mice. Shown is the total number of GFP-expressing cells in the spleen (Spl), skin, and
epidermis (Epi) at day 4 (upper panels), or the spleen and epidermis at days 14–17 (lower panels) post transfer. Note that following Trm cell maturation at > day 14,
the number of CD103+ Trm cells in skin is shown. Data are pooled from 2–3 experiments (n = 6–10 mice per group). Error bars represent mean ± SEM. See also
Figure S1.retrovirus (Figure S1A). Overexpression of either Eomes or T-bet
did not change the expression of various surface markers such
as CD44, Ly6C, and chemokine receptors CCR7 and CXCR6
(Figure S1B). In contrast, T cells transduced with the T-bet
expression vector displayed higher levels of CD122 and
CXCR3, both known to be induced by this TF (Matsuda et al.,
2007), whereas the Eomes-containing vector resulted in a slight
reduction in the latter molecule.
Retrovirus-transduced CD8+ T cells were transferred by intra-
dermal injection and identified in recipient mice as shown in
Figure S1C. Some transferred cells were retained in the
skin, while others made their way to the circulation and could
be found in the spleen. Recovery of injected cells from the spleen
was not affected by the forced Eomes expression, while
there were far fewer Eomes-transduced T cells in the epi-
dermal layer at either 4 or > 14 days after intradermal injection
(Figure 3A) compared to cells transduced with control vectors.
Thus, Eomes expression significantly inhibited CD103+ Trm
cell development (as detectable by day 14). Importantly, high
T-bet expression had a similar effect, with T-bet transduced cells
being severely compromised in their ability to form Trm cells in
the epidermis (Figure 3B). Therefore, downregulation of T-box
TF expression is required for epidermal entry and/or survival,
and CD8+CD103+ Trm cell formation in skin.
T-box Transcription Factors and TGF-b Receptor
Signaling Operate in a Feed-Forward Loop, Which
Is Required for Efficient Trm Cell Formation in the Skin
Epidermis
We and others have shown that TGF-b is required for Trm cell
development in peripheral tissues such as the skin and gut,
and that this cytokine drives the upregulation of the Trm cell
markers CD103 and to a lesser extent CD69 (Casey et al.,
2012; Mackay et al., 2013; Sheridan et al., 2014; Skon et al.,
2013; Zhang and Bevan, 2013). Furthermore, it has been shown
that TGF-b signals can negatively regulate T-bet expression in1104 Immunity 43, 1101–1111, December 15, 2015 ª2015 Elsevier InCD8+ T cells (Laidlaw et al., 2014). We therefore wanted to deter-
mine when TGF-b signaling was required during Trm cell matura-
tion, and whether this correlated with the downregulation of
the other T-box TF Eomes, as well as T-bet. Wild-type OT-I
T cells (specific for ovalbumin [OVA]) and TGF-bR deficient
OT-I T cells (OT-I.Tgfbr2f/fLck-Cre; henceforth referred to as
OTI.Tgfbr2/) were transferred into mice that were subjected
to infection with recombinant HSV expressing ovalbumin (HSV-
OVA). As shown in Figure 4A, similar numbers of wild-type and
TGF-bR deficient cells infiltrated infected skin early after infec-
tion. However, whereas wild-type cells upregulated CD103, the
TGF-bR-deficient cells failed to do so (Figure 4B). OT-I T cells un-
able to respond to TGF-b signals were significantly impaired in
their ability to enter and/or survive in the epidermal layer and
were significantly reduced in number in this compartment
compared to their wild-type counterparts after HSV infection
(Figure 4A, right panel) or following in vitro activation and intra-
dermal transfer (Figure S2A, right panel).
Not only were the TGF-bR deficient cells inefficient in
epidermal entry and Trm cell formation, but they also expressed
higher levels of both Eomes and T-bet in skin and epidermis
(Figure 4C) demonstrating a role for TGF-b in downregulating
the T-box TFs in these Trm cell-forming compartments. Note
that Eomes and T-bet expression levels were unchanged on
OT-I T cells in the circulation. In addition, we also found a reverse
association between TGF-bR itself and T-box TFs. Retrovirus-
transduced cells that expressed high levels of Eomes or T-bet
showed depressed levels of TGF-bR expression (Figures 4D
and S2B). In line with this, forced expression of these TFs re-
sulted in an inability to respond to TGF-b signals, as detected
by CD103 upregulation (Figures 4E and S2C). Moreover,
following the transfer of Eomes and T-bet overexpressing cells
into the skin, we found reduced expression of CD69 and the in-
tegrin CD49a (Figure S2D), which are Trm cell-associated mole-
cules dependent on TGF-b signaling (Zhang and Bevan, 2013).
It should be noted that CD103 is not expressed by T cells inc.
AEomes
C
# 
O
T-
I /
 s
ki
n 
cm
2  
0
2
4
6
8
10
# 
O
T-
I /
 e
pi
 c
m
2   
 
0
2
4
6
8
10
W
T
Tg
fbr
2
-/-
W
T
Tg
fbr
2
-/-
OT-I.Tgfbr2-/-
OT-I.WT
Isotype
T-bet
Skin Epi
Skin Epi
TGFβRII
Eomes+
Ctrl
Isotype
TGFβRII
T-bet+
Ctrl
Isotype
OT-I.Tgfbr2-/-OT-I.WT
CD103
E
om
es
5.1 0.4
7023.7
24.6 0.1
0.475
B
D
Ct
rl  
Eo
me
s+
0
20
40
60
80
Ct
rl  
T-
be
t+
0
20
40
60
80
%
 C
D
10
3 
in
du
ct
io
nE
Spl
0 103 104
0
100
0 103 104 0 103 104
0 103 104
0
103
104
105
0 103 104 105 0 103 104 105
0 103 104
0 103 104
0
100
0
100
0 103 104 0 103 104
%
 o
f m
ax
 
(×
 1
02
)
(×
 1
03
)
%
 o
f m
ax
 
%
 o
f m
ax
 
**
**
***
Figure 4. TGF-b Signaling and T-box Tran-
scription Factor Regulation
(A–C) Mice received equal numbers of wild-type
OT-I (WT) and OT-I.Tgfbr2/ (Tgfbr2/) T cells and
were infected with HSV-OVA. (A) Shown is
enumeration of OT-I T cells in skin and epidermis
(Epi) 14 days p.i. Symbols represent individual mice.
Data are pooled from two experiments (n = 10 mice/
group). (B) Intracellular staining for Eomes and
CD103 expression by OT-I T cells in skin at day 14
p.i.; numbers depict percent events in respective
gates. (C) Histograms show expression levels of
Eomes (upper panels) and T-bet (lower panels) by
OT-I.WT (black line) or OT-I.Tfbr2/ (orange line)
T cells at 14d p.i. Data are representative of two
experiments.
(D and E) In vitro activated CD8+ T cells were trans-
duced with either control-GFP (Ctrl) retrovirus or
Eomes-GFP (Eomes+) or T-bet-GFP (T-bet+) retro-
virus. (D) Representative histograms show expres-
sion of TGF-bRII levels by GFP-expressing cells,
as indicated (72 hr post transduction). (E) Trans-
duced cellswere treatedwith TGF-b for 48 hr in vitro.
Bar graphs show percent of CD103 induction.
Data are representative of 2–3 experiments. Error
bars represent mean ± SEM. See also Figure S2.skin at early times after transfer (Figure S2D), and cells lacking
this integrin subunit were not compromised in lodgement or sur-
vival for at least 14 days after transfer (Figure S2E). Combined,
the data suggest that T-box TFs and the cytokine TGF-b operate
in a feedforward loop during Trm cell development, where TGF-b
drives the downregulation of the T-box TFs, which in turn pro-
motes increased signaling via the cytokine receptor.
T-bet Elimination Results in Increased Proportion of
KLRG1– Trm Cell Precursors and an Initially Greater
Lodgement of CD8+CD103+ Trm Cells
Given that forced T-bet expression inhibited skin Trm cell forma-
tion, we wanted to determine whether its downregulation would
promote early development of these memory cells. It should be
noted that here we only focus on initial Trm cell lodgement (up
to day 7), with longer-term survival examined in the next section.
We began by using T cells homozygous or heterozygous forA
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(A and C) Symbols represent individual mice. Data are pooled from three experim
(D) KLRG1 and CD103 expression in skin by OT-I.WT and OT-I.Tbx21/ T cells
mean ± SEM. See also Figure S3.
ImmTbx21 (the gene encoding T-bet), which express lower amounts
of T-bet. Although it has been reported that complete loss of
T-bet results in increased Eomes expression (Takemoto et al.,
2006), this is not the case for the OT-I T cells after HSV-OVA
infection (Figure S3A). Thus, all changes in Eomes expression
in skin memory Tbx21/ T cells are likely to be a consequence
of Trm cell maturation.
Low numbers of naive OT-I T cells that were either Tbx21+/+
(wild-type) or Tbx21+/ (heterozygous) were transferred into
recipient mice, and subsequently subjected to skin infection
with HSV-OVA. At day 7 post infection, there was a modest
increase in the number of CD103+ Trm cells in skin for
Tbx21+/ cells compared to their Tbx21+/+ counterparts (Fig-
ure 5A, left panel). Although this difference did not reach statis-
tical significance, the increase in Trm cell numbers should be
viewed in the context of a significant decrease in overall splenic
memory T cell numbers for Tbx21+/ cells (Figure 5A, middleSkin
OT-I.Tbx21-/-
OT-I.Tbx21-/-
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Figure 5. Enhanced Trm Cell Lodgment in
the Absence of T-bet
Mice received equal numbers of wild-type
OT-I (Tbx21+/+) and (A) OT-I.Tbx21+/ or (B–D)
OT-I.Tbx21/ T cells and were infected with
HSV-OVA. OT-I T cells were identified by Va2
expression and distinct patterns of CD45.1 and
CD45.2. (A) Shown is enumeration of OT-I
(Tbx21+/+) and OT-I.Tbx21+/ T cells in skin
(CD103+ Trm cells) and spleen (Spl) 7 days p.i. Bar
graphs (right panel) show percent of OT-I T cells in
skin that express the Trm cell marker CD103. (B)
Plots show KLRG1 expression in the spleen and
skin by OT-I.WT and OT-I.Tbx21/ T cells 7 days
p.i. (C) Enumeration of OT-I (Tbx21+/+) and
OT-I.Tbx21/ T cells in skin (CD103+ Trm cells)
and spleen (Spl) 7 days p.i. Bar graphs as in (A).
ents (n = 14–19 mice per group).
7 days p.i. Data are representative of three experiments. Error bars represent
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Figure 6. Defective Trm Cell Survival in the
Absence of T-bet
(A) Mice received equal numbers of wild-type (WT)
OT-I (Tbx21+/+) and OT-I.Tbx21/ (Tbx21/)
T cells and were infected with HSV-OVA. Shown is
enumeration of OT-I T cells in skin (CD103+ Trm
cells) 14 days p.i.
(B) Mice received equal numbers of in vitro acti-
vated CD8+ wild-type (Tbx21+/+) and Tbx21/
T cells by intradermal injection into skin. Shown is
enumeration of CD8+ T cells in skin (CD103+ Trm
cells) 14 days post transfer.
(C) Same as in (A) following co-transfer of WT OT-I
(Tbx21+/+) and OT-I.Tbx21+/ (Tbx21+/) T cells.
Bar graphs (right panel) show percent of total OT-I
T cells in skin that express the Trm cell marker
CD103. Symbols represent individual mice. All
data are pooled from 2–3 experiments (n = 11–17
mice/group). Error bars represent mean ± SEM.
(D) Intracellular staining for Eomes and CD103
expression byOT-I.Tbx21/ T cells in skin at day 7
p.i. HSV-OVA; numbers depict percent events in
respective gates. Histogram shows CD122
expression by Eomes+ CD103 or Eomes
CD103+ fractions, as indicated.
(E) Representative histograms show CD122
expression in skin (left panel) by OT-I.WT (black
line) and OT-I.Tbx21/ (orange filled) T cells
14 days p.i. HSV-OVA; (middle panel) by in vitro
activated CD8+WT (black line) and CD8+ Tbx21/
(orange filled) T cells 14 days post intradermal
transfer; and (right panel) by OT-I.WT (black line)
and OT-I.Tbx21+/ (purple filled) T cells 14 days p.i.
HSV-OVA.
(F) OT-I.WT and OT-I.Tbx21/ T cells were iso-
lated from the skin 7 days p.i. HSV-OVA and were
stimulated for 4 hr in vitro with PMA and Ion-
omycin. Histogram (left panel) shows intracellular
staining for IFN-g by OT-I.WT (black line) OT-
I.Tbx21/ (red line) and non-stimulated T cells
(gray filled). Contour plots show expression of
Eomes and IL-17 by OT-I T cells as indicated;
numbers depict percent events in respective
gates. Histogram (right panel) shows RORgt
expression by Eomes+ IL-17 or Eomes IL-17+
OT-I.Tbx21/ T cells. Data are representative of
two experiments. See also Figures S3–S5.panel), the latter due to the requirement for T-bet to generate a
complete short-lived effector cell pool following viral infection
(Joshi et al., 2007). The proportion of total skin T cells expressing
the mature CD103+ Trm cell phenotype was significantly higher
in the Tbx21+/ cells (Figure 5A, right panel). Thus, even a
modest reduction in T-bet promoted Trm cell formation.
Given the above, we wanted to determine whether complete
elimination of T-bet would also promote greater lodgement of
Trm cell precursors in the skin. Wild-type Tbx21+/+ or Tbx21/
OT-I T cells were transferred into recipient mice, which were
then infected with HSV-OVA. As expected, Tbx21/ cells in
both spleen and skin showed a preferential skewing toward cells
with low KLRG-1 expression (Figure 5B), which are the precur-
sors of Trm cells (Mackay et al., 2013). Consistent with this
increased precursor frequency, T-bet-deficient T cells were
recovered in significantly greater numbers from the skin at
day 7 post infection compared to their wild-type counterparts.1106 Immunity 43, 1101–1111, December 15, 2015 ª2015 Elsevier InFurthermore, a larger proportion of T-bet-deficient cells ex-
pressed CD103 (Figure 5C, D). Thus, complete elimination
of T-bet expression results in the preferential production of
KLRG-1 memory cell precursors, with a concomitant increase
in CD103+ Trm cell lodgement early after the resolution of skin
infection.
T-bet-Deficient Trm Cells Show Defective IL-15Rb
Expression and Aberrant Cytokine Production and
Disappear from the Skin over Time
Despite the enhanced CD103+ Trm cell formation by T-bet defi-
cient OT-I T cells seen at day 7 post infection (Figure 5C), the
vast majority of these cells were lost by day 14 from the skin
(Figure 6A). T-bet deficient CD103+ Trm cells remaining at day
14 after HSV infection showed lower Bcl-2 levels, suggesting
that survival in these few cells was also likely to be compromised
(Figure S4A). Tbx21/ Trm cells could not be rescued by Eomesc.
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Figure 7. IL-15 Signaling Is Required for
Initial Trm Cell Lodgment and Memory Trm
Cell Survival
(A and B) Mice received naive gBT-I T cells and
were infected on the flank with HSV. Mice were
treated with aIL-15+IL-15R or PBS (Ctrl) by intra-
dermal injection at the site of skin infection for
6 days (A) during Trm cell lodgment (days 7–13 p.i.)
or (B) during thememory phase subsequent to Trm
cell lodgment (> day 30 p.i.). Shown is enumeration
of gBT-I T cells in spleen (Spl) and CD103+ Trm
cells in skin (n = 9–10 mice per group).
(C) Mice received naive OT-I T cells and were in-
fected intranasally with X31-OVA. Mice were
treated with aIL-15+IL-15R or PBS (Ctrl) by i.p.
injection for 6 days > day 14 p.i. Shown is
enumeration of OT-I T cells in the spleen (Spl) and
CD69+CD103+ (CD103+) and CD69+CD103
(CD103) in the lung (n = 10 mice per group). Data
are pooled from two experiments. Error bars
represent mean ± SEM.overexpression (Figure S4B), indicating that Eomes was either
deleterious for Trm cell formation or that it simply could not
efficiently substitute for T-bet in this particular subset. In
contrast, T-bet deficient memory T cells in the circulation main-
tained Eomes expression (Figure S3A), unlike their CD103+
counterparts in the skin that downregulate this TF as part of their
maturation program (Figures 2 and S3B).
The preferential loss of T-bet-deficient Trm cells compared to
their wild-type counterparts was also seen following injection of
in vitro activated CD8+ Tbx21/ T cells directly into the skin (Fig-
ures 6B and S4C). Note that OT-I T cells heterozygous for T-bet
were not lost from the skin, but instead were biased toward the
CD103+ Trm cell phenotype when compared to wild-type cells
(Figure 6C). Thus, T-bet-deficient cells are lost over time despite
their superior lodgement in skin early after infection. In contrast,
Eomes deficiency was compatible with normal Trm cell develop-
ment and maintenance in the skin (Figures S4D and S4E). These
data established that the complete loss of T-bet, but not Eomes,
was detrimental to long-term Trm cell survival.
T-bet-deficient CD103+ Trm cells in the skin downregulated
Eomes expression similar to their wild-type counterparts, effec-
tively rendering them devoid of all T-box TF activity (Figure S3B).
It has been reported that T cells lacking both Eomes and T-bet
have defective expression of the b-chain (CD122) of the IL-15
receptor (Intlekofer et al., 2005). Given this, we hypothesized
that impaired survival of T-bet deficient Trm cells was due to
defective IL-15 signaling. In line with this idea, we found defec-
tive CD122 expression specifically in CD103+ Tbx21/ Trm cells
that had downregulated Eomes early during maturation (Fig-
ure 6D). CD122 expression remained decreased on Tbx21/
OT-I T cells (Figure 6E, left panel) and on in vitro stimulatedImmunity 43, 1101–1111, DeTbx21/ CD8+ T cells lodged by direct
intradermal injection (Figure 6E, middle
panel) even at later times clearly impli-
cating impaired IL-15 signaling in the
impaired survival of T-bet deficient Trm
cells. In contrast, CD122 expression
levels were equivalent between wild-type OT-I and OT-I.Tbx21+/ T cells (Figure 6E, right panel),
which was consistent with their similar survival in skin.
In addition to the lack of CD122 expression, we found that
T-bet deficient skin T cells that downregulated Eomes made
less IFN-g and secreted IL-17 with concomitant RORgt upregu-
lation (Figure 6F). CD8+ T cells deficient for both Eomes and
T-bet have been shown to ectopically upregulate RORgt and
IL-17 (Intlekofer et al., 2008), so the altered cytokine production
was consistent with T-bet deficient skin T cells being effectively
T-box TF negative once Eomes is downregulated. Thus, loss
of T-bet has a profound effect on both Trm cell survival and
the pattern of cytokine expression, which is likely linked to the
downregulation of Eomes during the final stages of Trm cell
development.
IL-15 Signaling Is Required for Ongoing Trm Cell
Survival in Non-lymphoid Tissues
The concomitant failure in CD122 upregulation and Trm cell
persistence of T-bet deficient T cells is consistent with the estab-
lished role of IL-15 signaling in Trm cell development (Mackay
et al., 2013). While Trm cell development was found to be
impaired in IL-15 deficient mice, it was not clear whether the
cytokine was just required for Trm cell formation or whether it
also played a role in their subsequent survival. To address this,
we administered neutralizing antibody specifically targeting the
IL-15 and IL-15R complex. This antibody was injected into the
skin flank at the site of Trm cell establishment, at two different
periods following infection with HSV. We found that the number
of skin Trm cells was diminished bymore than half following anti-
body administration relatively early during the Trm cell formation
phase (treatment day 7–13 post infection [p.i.] HSV, Figure 7A),cember 15, 2015 ª2015 Elsevier Inc. 1107
and also long after the Trm cell pool had been established (treat-
ment > day 30 p.i. HSV, Figure 7B). Therefore, ongoing IL-15
signaling is required for skin Trm cell survival.
To extend our observation to another setting, we examined
the IL-15 dependence of lung Trm cells. For these experiments,
we transferred OT-I T cells into C57BL/6 mice and infected with
recombinant influenza virus expressing the target determinant
from ovalbumin (X31-OVA). Similar to CD8+CD103+ Trm cells
in the skin, the corresponding subset in lungs showed downre-
gulation of Eomes and T-bet expression (Figure S5A) with the
decrease in Eomes and T-bet most pronounced in the mature
CD103+ population (Figures S5B and S5C). Moreover, similar
to our results in the skin, T-bet elimination resulted in a pro-
nounced loss of CD8+CD103+ Trm cells from the lung by day
14 after infection despite enhanced early lodgement (Fig-
ure S5D). Neutralization of the IL-15 and IL-15R complex by
antibody injection showed that Trm cell survival in the lung was
IL-15 dependent (Figure 7C). Interestingly, when we separately
examined lungmemory T cells based on their relative expression
of CD103, only the CD103+ T cells showed this reliance on IL-15
for ongoing survival (Figure 7C, right panel). Overall, the com-
bined data suggest that skin and lung CD8+CD103+ Trm cells
mirror each other in T-box TF requirements and, most critically,
in their dependence on IL-15 signaling.
DISCUSSION
It is now emerging that Trm cells consist of different subsets, with
varying expression of the markers CD69 and CD103 (Steinert
et al., 2015; Watanabe et al., 2015). The CD8+CD103+ Trm cells
form a transcriptionally distinct group (Wakim et al., 2012), which
is found in a variety of different non-lymphoid organs, including
the lung, skin, gut, and thymus (Casey et al., 2012; Hofmann
et al., 2013; Hu et al., 2015; Mackay et al., 2013). In our study,
we used antibody ablation to formalize two important character-
istics for this population. First, we demonstrated that the
CD8+CD103+ Trm cells have stand-alone protective capability.
This is critical, because prior assessments of Trm cell-mediated
protection were done in the presence of circulatingmemory cells
(Mackay et al., 2012; Schenkel et al., 2014; Shin and Iwasaki,
2012), leaving open the possibility that infection control involved
or even relied on recruitment from the blood. Separately, the
experiments also showed that CD8+CD103+ skin T cells were
truly resident, as distinct from a subset of skin T cells that only
expressed CD69 and were eliminated by antibody depletion.
While it has been shown that CD69+CD103 T cells do not recir-
culate in some circumstances (Bergsbaken and Bevan, 2015;
Steinert et al., 2015), our results argue that caution should be
exercised when using CD69 as the sole Trm cell marker.
Having established the credentials for CD8+CD103+ Trm cells,
we then focused on elucidating the role of the T-box TFs T-bet
and Eomes during their development. While the importance of
T-bet downregulation had been flagged by Laidlaw et al. (2014)
for CD8+CD103+ Trm cells in the lung, those studies stopped
short of examining the combined T-box TFs Eomes and T-bet
as well as determining how they separately controlled Trm cell
development. We found that, like T-bet, Eomes was also down-
regulated during Trm cell development, although to a much
greater extent. Skin Trm cells virtually extinguish Eomes expres-1108 Immunity 43, 1101–1111, December 15, 2015 ª2015 Elsevier Insion and do so quite late in the maturation program, either just
before or just after the cells enter the epithelium and prior to
the appearance of cell surface CD103. Leaving the matter of
Eomes levels aside for the time being, the co-ordinated downre-
gulation of both T-box TFs represents a pivotal step in Trm cell
formation, since it was found to result in enhanced TGF-b
signaling. This cytokine has been shown to be critical for
CD8+CD103+ Trm cell development in a variety of tissues (Sher-
idan et al., 2014; Zhang and Bevan, 2013). We found that TGF-b
signaling downregulated the T-box TFs, suggesting these both
this cytokine and the T-box TFs are involved a feedforward
loop that optimizes CD8+CD103+ Trm cell formation.
At face value, the earlier demonstration that T-bet modulation
drove lung CD8+CD103+ Trm cell development (Laidlaw et al.,
2014) implied that its complete elimination would have much
the same effect. Initially, we found this to be the case, with
T-bet deficient CD8+ T cells showing early lodgement in the
skin and acquisition of the mature CD103+ phenotype. More-
over, the enhancement correlated with an increase in Trm cell
precursor frequencies. T-bet deficiency favors development of
KLRG-1CD127+ memory precursor effector cells (MPECs)
(Joshi et al., 2007), which are also the CD8+CD103+ Trm cell
precursors (Mackay et al., 2013; Sheridan et al., 2014). In skin,
KLRG-1- MPECs migrate into the epidermis after the resolution
of HSV infection to form epidermal-lodged Trm cells (Mackay
et al., 2013). In a related fashion, Sheridan et al. (2014) have
shown that MPECs preferentially lodge in the intestinal mucosa
after Listeria monocytogenes infection and, there, rapidly
convert to CD103+ Trm cells under the influence of local TGF-b
stimulation.
However, despite exhibiting enhanced early lodgement in both
skin and lung, the T-bet deficient CD8+CD103+ Trm cells were
found to ultimately disappear over time. We propose that this
disappearance is an indirect consequence of an effective lack
of Eomes expression by the mature CD8+CD103+ Trm cells.
Eomes shut-down is a striking feature that spans CD8+CD103+
Trm cells in a variety of different tissues including the skin and
lung (Mackay et al., 2013; Wakim et al., 2012). This means that
in cells that are genetically defective in Tbx21, Eomes extinguish-
ment results in complete loss of T-box TF expression. Total
T-box deficiency in CD8+ T cells leads to altered functionality
for this subset, with decreased IFN-g production offset by the
appearance of RORgt and IL-17 (Intlekofer et al., 2008). In line
with this, we found that a proportion of T-bet deficient cells
that downregulated Eomes could express RORgt and IL-17.
More importantly, Intlekofer et al. (2005) also showed that at least
one T-box TF was necessary to maintain expression of the cyto-
kine receptor subunit CD122. As a consequence, skin T cells that
genetically lacked T-bet and downregulated Eomes had little
surface expression of the IL-15R b-chain. IL-15 is a prerequisite
for Trm cell development (Mackay et al., 2013) and, as shown
here in experiments using anti-IL-15 and IL-15R antibody
blockade, it is also critical to the survival of Trm cells once lodged
in the skin. Therefore, our results reveal a Trm cell-T-bet depen-
dency that is linked to IL-15 signaling and set up by the loss of
Eomes during the maturation process.
Putting the mechanisms described here in a broader context
of tissue residency, the association between IL-15 and T-bet
dependency for skin Trm cells mirrors what has been reportedc.
for tissue-resident cells that form part of the innate system. Tis-
sue-resident NK cells in skin and liver show similar patterns of
low Eomes expression as well as IL-15 and T-bet-dependence
(Sojka et al., 2014). In terms of other innate cells, CD8aa TCRab
CD103+ intra-epithelial lymphocytes (IELs) that reside in the in-
testinal mucosa appear to have a similar multifactorial depen-
dence (Klose et al., 2014; Reis et al., 2014). These natural IELs
are Eomeslo and derive from distinct thymic T cell precursors
that mature in the intestine in a TGF-b- and IL-15-dependent
manner (Cheroutre et al., 2011). The IL-15 dependence for the
CD8aa IELs is a consequence of T-bet driven CD122 expression
(Reis et al., 2014), matching the results here for CD8+CD103+
Trm cells in both the skin and lung. Thus, some of the transcrip-
tional regulations defined here for Trm cells are likely to be com-
mon to a variety of tissue-resident cells from both the innate and
adaptive arms of the immune response.
In summary, our data reveal that both Eomes and T-bet are
tightly regulated during Trm cell development and provide a
critical interface with the cytokines TGF-b and IL-15. The Eomes
extinguishment during the final stages of maturation renders skin
CD8+CD103+ Trm cells completely T-bet dependent for their
survival. One could envisage that under certain circumstances,
elements involved in Trm cell development might be replaced
by related factors, such as other cytokines that signal through
of common g-chain receptors acting as alternatives to IL-15.
Given the complexity of this system and interdependence be-
tween the various components, changes that affect parameters
such as the timing of T-box TF modulation and the coordination
with TGF-b availability would also have a profound effect on Trm
cell maturation. This, in turn, would directly affect the extent to
which CD8+CD103+ Trm cells dominate the local response and
mediate immunity within a given tissue. Understanding the
various drivers of Trm cell development will permit optimization
of their lodgement or survival for more effective immunity at
pathogen entry points throughout the body.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, B6.SJL-PtprcaPep3b/BoyJ (B6.CD45.1), B6.Thy1.1, gBT-I, gBT-
I.Itgae/, OT-I, Tbx21/, OT-I.Tbx21/, OT-I.Tbx21+/, and OT-I.Eomes/
mice were bred in the Department of Microbiology and Immunology, The
University of Melbourne. Female mice 6–12 weeks of age were used for exper-
iments. The gBT-I and OT-I mice are CD8+ TCR transgenicmice that recognize
the H-2Kb-restricted HSV-1 gB epitope of amino acids 498–505 (gB498–505)
and the ovalbumin-derived epitope of amino acids 257–264 (OVA257–264),
respectively. OT-I.Tgfbr2f/f.dLck-Cre mice were kindly provided by M. Bevan
(University of Washington). All animal experiments were approved by The Uni-
versity of Melbourne Animal Ethics Committee.
Virus Infections and Determination of Viral Titers
Viruses usedwere the KOS strain of HSV-1 (HSV) andHSV-OVA (Mackay et al.,
2013). Epicutaneous infection by scarification was carried out using 1 3 106
PFU HSV as described (Gebhardt et al., 2009). For influenza infections, 1 3
104 PFU X31-OVA (kindly provided by S. Turner) was administered intrana-
sally. The level of infectious virus following HSVwas determinedwithin homog-
enized skin by standard PFU assays.
T Cell Transfers and In Vitro Activation
Adoptive transfers of naive gBT-I or OT-I T cells were carried out intravenously
(i.v.) with lymph node suspensions. Naive gBT-I or OT-I T cells were transferred
at a total number of 53 104 or 2.53 104 cells/population in co-transfer exper-Immiments, where cell typeswere transferred at a ratio of 1:1. For polyclonal in vitro
activation of CD8+ T cells, CD8-enriched splenocytes were activated by
anti-CD3ε (145-2C11) and anti-CD28 (37.51) (5 mg/ml, eBioscience). For ex-
periments where T cells were transferred by intradermal injection, 1–5 3 106
activated cells were transferred into recipients as described (Mackay et al.,
2013). For experiments utilizing DNFB to lodge Trm cells for HSV challenge
experiments, 1 3 107 gBT-I.Thy1.1+ T cells were transferred i.v. and the
skin flank was treated with 0.3% DNFB (Sigma-Aldrich), as described
(Mackay et al., 2012).
Cytokine Treatments
For IL-15 blocking assays, mice were treated with anti-IL-15+IL-15R a chain
antibody (7.5 mg/d, eBioscience) for 6 consecutive days by either intradermal
injection (for experiments using HSV) or intraperitoneal injection (for experi-
ments using influenza). For CD103 upregulation in vitro, CD8+ T cells were
treated for 48 hr with 5 ng/ml recombinant TGF-b. For depletion of circulating
memory cells, mice were treated by intraperitoneal injection with 1 mg antibody
to Thy1.1 (HIS51, BD Biosciences).
Retroviral Constructs and Transduction of CD8+ T Cells
Murine stem cell virus (MSCV)–T-bet–internal ribosome entry site (IRES)–GFP
has been previously described (Joshi et al., 2007), and MSCV-Eomes-IRES-
GFP and MSCV-IRES-GFP were provided by Professor Gabrielle Belz
(WEHI). In vitro activated CD8+ T cells were spin-infected with retroviral
supernatant 2d following activation in the presence of 1 mg/mL polybrene
(Sigma-Aldrich) and 50 U/mL IL-2, and then expanded for a further 2–4 days
in IL-2-containing medium. Transduction efficacy was determined by GFP
expression and transduced cells (CD45.1+) were transferred into C57BL/6
recipients by intradermal injection.
Flow Cytometry and Antibodies
T cells were recovered from skin as described (Mackay et al., 2012). Briefly,
skin tissue was incubated for 90 min at 37C in dispase (2.5mg/ml) followed
by the separation of epidermis and dermis. Epidermal sheets were subse-
quently incubated for 30 min in trypsin/EDTA and remaining skin tissue was
chopped into small fragments and incubated for 30 min at 37C in collagenase
type 3 (3 mg/ml). For recovery of T cells from the lung, mice were injected i.v.
with 3 mg of Alexa Fluor 700-conjugated antibody to CD3 10 min prior to sac-
rifice, andmicewere then perfused before the collection of lung tissue that was
digested for 90 min in collagenase type 3 (3 mg/ml). Cell suspensions were
stained with antibodies for flow cytometry. For intracellular staining, cells
were fixed using Foxp3/Transcription Factor Staining Buffer Set (eBioscience)
before staining with intracellular antibodies. For intracellular cytokine secretion
assays, cells were incubated for 4 hr with PMA and Ionomycin in the presence
of Brefeldin A. The following antibodies were purchased from BD PharMingen:
anti-CD45.1 (A20), CD45.2 (104), Va2 (B20.1), CD8a (53-6.7), TCR-b
(H57-597), Bcl-2 (3F11), and IL-17A (Tc11-18H10). The following antibodies
were purchased from eBioscience: anti-CD45.1 (A20),CD45.2 (104),CD8a
(53-6.7), CD3 (500A2), anti-CD103 (2E7), KLRG1 (2F1), CD122 (TM-b1),
T-bet (4B10) Eomes (Dan11mag), and RORgt (AFKJS-9); anti-CXCR3
and -TGF-bRII were purchased from R&D.
qPCR
gBT-I T cells were isolated from skin and purified by cell sorting as PI–Va2+
CD45.2+CD45.1+KLRG1–CD103+/– events as indicated. RNA extraction,
cDNA synthesis, preamplification and qPCR were performed using Taqman
Gene Expression Cells-To-Ct Kit, Taqman Fast Preamp master mix and Taq-
man assays. The threshold cycle of respective genes for each cell population
was normalized to the mean of Hprt, b2m, and Tbp (DCt). Normalized gene
expression was compared to that of the Trm cell population according to
the 2-DDCT method.
Statistical Analysis
All statistics were calculated using the two-tailed Mann-Whitney test and
GraphPad Prism (GraphPad Software). * p < 0.05, **p < 0.01, ***p < 0.001,
and ****p < 0.0001.unity 43, 1101–1111, December 15, 2015 ª2015 Elsevier Inc. 1109
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